The Women's Health Initiative recruitment methods and results.

One of the most challenging aspects of the Women’s Health Initiative (WHI) was the recruitment of more than 161,000 women for this long-term prevention trial and observational study. The WHI had many enrollment goals that made recruitment efforts formidable (1). These included the recruitment of postmenopausal women, a group seldom targeted for clinical trials; enrolling minority groups in at least the same proportion as they existed in the general population; and enrolling women willing to participate in a long-term (8–12 year) study. The success of the WHI in meeting these goals can be attributed to several factors: the experience gained from prior studies, such as the National Cancer Institute (NCI)-sponsored Women’s Health Trial (2), the subsequent Women’s Health Trial Feasibility Study in Minority Populations (3), and the Postmenopausal Estrogen/Progestin Interventions Trial (4); detailed planning by the WHI investigators; the dedication of recruiters, staff, and investigators at the clinical centers; and, a social and political climate that enhanced women’s interest in health research. Prior to the WHI, few large-scale prevention or clinical trials focused on postmenopausal women. Indeed, until recently, relatively little emphasis was placed on the recruitment of women of any age into such studies (5). However, during the last decade, a number of forces have come together to change this situation. The stance that women

[1]  L. Appel,et al.  Recruitment and retention of minority participants in the DASH controlled feeding trial. DASH Collaborative Research Group. Dietary Approaches to Stop Hypertension. , 1998, Ethnicity & disease.

[2]  G. Swanson,et al.  Recruiting minorities into clinical trials: toward a participant-friendly system. , 1995, Journal of the National Cancer Institute.

[3]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.

[4]  J. Bennett,et al.  Inclusion of women in clinical trials--policies for population subgroups. , 1993, The New England journal of medicine.

[5]  W. El-Sadr,et al.  The challenge of minority recruitment in clinical trials for AIDS. , 1992, JAMA.

[6]  N. Borhani,et al.  Mass mailing and staff experience in a total recruitment program for a clinical trial: the SHEP experience. Systolic Hypertension in the Elderly Program. Cooperative Research Group. , 1999, Controlled clinical trials.

[7]  Bennett Jc Inclusion of women in clinical trials--policies for population subgroups. , 1993 .

[8]  N. Borhani,et al.  Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Trials of Hypertension Prevention (TOHP) Collaborative Research Group. , 1995, Annals of epidemiology.

[9]  M. Moskowitz,et al.  Feasibility of a randomized trial of a low-fat diet for the prevention of breast cancer: dietary compliance in the Women's Health Trial Vanguard Study. , 1990, Preventive medicine.

[10]  V. Pinn,et al.  The evolution of the Women's Health Initiative: perspectives from the NIH. , 1995, Journal of the American Medical Women's Association.

[11]  R. Coates,et al.  Recruitment and retention of subjects for a longitudinal cancer prevention study in an inner-city black community. , 1995, Health services research.

[12]  C. Lewis,et al.  The Women's Health Trial Feasibility Study in Minority Populations: design and baseline descriptions. , 1996, Annals of epidemiology.

[13]  D. Wermeling,et al.  Current Issues Surrounding Women and Minorities in Drug Trials , 1993, The Annals of pharmacotherapy.

[14]  D. B. Stoy,et al.  Recruitment of postmenopausal women in the PEPI Trial. Postmenopausal Estrogen/Progestin Interventions. , 1995, Controlled clinical trials.